Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024

May 2, 2024

https://www.globenewswire.com/news-release/2024/05/02/2874665/0/en/Ventyx-Biosciences-to-Report-First-Quarter-2024-Financial-Results-on-May-9-2024.html

SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq:VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that it will report financial results for the first quarter ended March 31, 2024 after market close on May 9, 2024. Company management will host a conference call and webcast beginning at 4:30 p.m. ET/ 1:30 p.m. PT that day to discuss the financial results and highlight recent pipeline and business progress.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.